John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test detects antihypertensive medications in urine, providing evidence of whether patients are absorbing their medications or whether a new treatment approach might be needed. 

Speaker 3: (00:33)
 Could you tell us a little about yourselves and your backgrounds?

Speaker 3: (01:41)
 Dr. Taler, could you provide us with a brief background on resistant hypertension?

Speaker 3: (03:43)
 Can you provide a little bit more background on patients who aren't taking their medications?

Speaker 3: (05:11)
 How do physicians currently assess whether patients are taking their medications?

Speaker 3: (07:03)
 Dr. Lieske, could you tell us how this new assay can be used to help physicians manage their patients with hypertension?

Speaker 3: (09:43)
 Dr. Taler, can you tell us how doctors can use this new testing to manage their patients?